

 
 
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
 
Most Trending
-0.75%
+3.18%
-0.99%
-2.27%
PPCB
Propanc Biopharma Inc.
$1.21
 Login to see Propanc Biopharma Inc. (PPCB)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to see Propanc Biopharma Inc. (PPCB)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Chart
$1.77 (-31.64%)
$2.94 (-58.84%)
$2.94 (-58.84%)
$2.94 (-58.84%)
PPCB has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

 
PPCB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Analysts perspectives on the stock desirability, trend direction, and growth potential.
What is PPCB current stock price?
What are PPCB stock strengths?
What risks are associated with PPCB stock?
When is PPCB next earnings report?
What is PPCB market cap and volume?
What is PPCB's current Stock IQ?
Should I buy PPCB stock right now?
Is PPCB a Strong Buy right now?
What does a 'Strong Buy' rating mean for PPCB?
What does a 'Strong Sell' rating mean for PPCB?
What factors influence PPCB's Stock IQ?
 
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.75%
+3.18%
-0.99%
-2.27%
PPCB
Propanc Biopharma Inc.
Current Price
$1.21
Chart
$1.77 (-31.64%)
$2.94 (-58.84%)
$2.94 (-58.84%)
$2.94 (-58.84%)
PPCB Analysts Opinion
 
PPCB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PPCB has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

Low volume

High volatilty

 
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PPCB Stock trends
PPCB Stock performance
PPCB Stock analysis
PPCB investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS"). 
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.